Jonathan R Whitfield

8PUBLICATIONS
42CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 19, 2025
MYC in cancer: from undruggable target to clinical trials.

Jonathan R Whitfield, Laura Soucek

|Feb 06, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trial.

Elena Garralda, Marie-Eve Beaulieu, Víctor Moreno

|Apr 06, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma.

Mariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini

|Mar 02, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding.

Daniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset

|Oct 09, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.

Chiara Pighi, Taek-Chin Cheong, Mara Compagno

|Jun 23, 2021
The long journey to bring a Myc inhibitor to the clinic.

Jonathan R Whitfield, Laura Soucek

Pageof 2